Clinical Trial Update: HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates that the HMPL-453 tartrate study is being evaluated in advanced intrahepatic cholangiocarcinoma (Phase 2/Phase 3) and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• HMPL-453 tartrate (HMPL-453 tartrate)

Snippet

Sponsor: Hutchmed | Conditions: Advanced Intrahepatic Cholangiocarcinoma, Solid Tumor, Adult | Phase 2, Phase 3 | Status: RECRUITING